FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1119-1124 April 21, 1994 Number 16 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Recent studies have suggested an association between higher body iron stores and the risk of coronary heart disease. To assess these findings, we examined the association between transferrin saturation and the risk of coronary heart disease, myocardial infarction, overall mortality, and mortality from cardiovascular causes in a large population.

Methods We studied a total of 4518 men and women from the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, using a multivariate Cox proportional-hazards model. Base-line data were collected from 1971 to 1974, with follow-up through 1987. Transferrin saturation (serum iron concentration divided by total iron-binding capacity) was used as a measure of the amount of circulating iron available to tissues.

Results The risk of coronary heart disease was not related to transferrin-saturation levels in white men or women. Estimates of the relative risk of coronary heart disease for the fifth quintile of transferrin saturation as compared with the first quintile were 0.72 (95 percent confidence interval, 0.51 to 1.00) for men and 0.85 (95 percent confidence interval, 0.60 to 1.21) for women. The results were similar for myocardial infarction. A significant inverse association with transferrin saturation was found for overall mortality and for mortality from cardiovascular causes in white men and women. Transferrin saturation was not associated with any of the clinical outcomes in blacks, possibly owing to the small sample.

Conclusions Higher transferrin-saturation levels were not associated with an increased risk of coronary heart disease or myocardial infarction. On the contrary, the results indicate that there may be an inverse association of iron stores with overall mortality and with mortality from cardiovascular causes. .

Source Information

From the National Center for Health Statistics, Centers for Disease Control and Prevention, 6525 Belcrest Rd., Rm. 1070, Hyattsville, MD 20782, where reprint requests should be addressed to Dr. Sempos.

Full Text of this Article

Related Letters:

Body Iron Stores and the Risk of Coronary Heart Disease
Salonen J. T., Nyyssonen K., Salonen R., Giles W. H., Anda R. F., Williamson D. F., Yip R., Marks J., Sempos C. T., Looker A. C., Gillum R. F., Makuc D. M.
Extract | Full Text  
N Engl J Med 1994; 331:1159-1160, Oct 27, 1994. Correspondence

This article has been cited by other articles:

• Kovesdy, C. P., Lee, G. H., Kalantar-Zadeh, K. (2008). Serum Ferritin: Deceptively Simple or Simply Deceptive? Lessons Learned From Iron Therapy in Patients With Chronic Kidney Disease. Journal of Pharmacy Practice 21: 411-419 [Abstract]  
• Sun, Q., Ma, J., Rifai, N., Franco, O. H., Rexrode, K. M., Hu, F. B. (2008). Excessive Body Iron Stores Are Not Associated with Risk of Coronary Heart Disease in Women. J. Nutr. 138: 2436-2441 [Abstract] [Full Text]  
• Edgren, G., Nyren, O., Melbye, M. (2008). Cancer as a Ferrotoxic Disease: Are We Getting Hard Stainless Evidence?. JNCI J Natl Cancer Inst 100: 976-977 [Full Text]  
• Edgren, G., Reilly, M., Hjalgrim, H., Tran, T. N., Rostgaard, K., Adami, J., Titlestad, K., Shanwell, A., Melbye, M., Nyren, O. (2008). Donation Frequency, Iron Loss, and Risk of Cancer Among Blood Donors. JNCI J Natl Cancer Inst 100: 572-579 [Abstract] [Full Text]  
• Lenga, I., Lok, C., Marticorena, R., Hunter, J., Dacouris, N., Goldstein, M. (2007). Role of Oral Iron in the Management of Long-Term Hemodialysis Patients. CJASN 2: 688-693 [Abstract] [Full Text]  
• Kalantar-Zadeh, K., Kalantar-Zadeh, K., Lee, G. H. (2006). The Fascinating but Deceptive Ferritin: To Measure It or Not to Measure It in Chronic Kidney Disease?. CJASN 1: S9-S18 [Abstract] [Full Text]  
• Wurzel, J., Goldman, B. I., Doria, A., Shoenfeld, Y., Pauletto, P., Violi, F., Loffredo, L., Ferro, D., Pezzetta, F., Mascitelli, L., Noel, B., Roman, M. J., Lockshin, M. D., Salmon, J. E., Stein, C. M., Hahn, B. H. (2004). Premature Coronary Disease in Systemic Lupus. NEJM 350: 1571-1575 [Full Text]  
• Wolff, B., Volzke, H., Ludemann, J., Robinson, D., Vogelgesang, D., Staudt, A., Kessler, C., Dahm, J. B., John, U., Felix, S. B. (2004). Association Between High Serum Ferritin Levels and Carotid Atherosclerosis in the Study of Health in Pomerania (SHIP). Stroke 35: 453-457 [Abstract] [Full Text]  
• Campbell, S, George, D K, Robb, S D, Spooner, R, McDonagh, T A, Dargie, H J, Mills, P R (2003). The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease. Heart 89: 1023-1026 [Abstract] [Full Text]  
• Ramakrishna, G., Rooke, T. W, Cooper, L. T (2003). Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light. Vasc Med 8: 203-210 [Abstract]  
• You, S.-A., Archacki, S. R., Angheloiu, G., Moravec, C. S., Rao, S., Kinter, M., Topol, E. J., Wang, Q. (2003). Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol. Genomics 13: 25-30 [Abstract] [Full Text]  
• Derstine, J. L, Murray-Kolb, L. E, Yu-Poth, S., Hargrove, R. L, Kris-Etherton, P. M, Beard, J. L (2003). Iron status in association with cardiovascular disease risk in 3 controlled feeding studies. Am. J. Clin. Nutr. 77: 56-62 [Abstract] [Full Text]  
• Turbino-Ribeiro, S. M. L., Silva, M. E., Chianca, D. A. Jr, de Paula, H., Cardoso, L. M., Colombari, E., Pedrosa, M. L. (2003). Iron Overload in Hypercholesterolemic Rats Affects Iron Homeostasis and Serum Lipids but Not Blood Pressure. J. Nutr. 133: 15-20 [Abstract] [Full Text]  
• Gaenzer, H., Marschang, P., Sturm, W., Neumayr, G.u., Vogel, W., Patsch, J., Weiss, G.u. (2002). Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 40: 2189-2194 [Abstract] [Full Text]  
• Ramakrishnan, U., Kuklina, E., Stein, A. D (2002). Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. Am. J. Clin. Nutr. 76: 1256-1260 [Abstract] [Full Text]  
• Fleming, D. J, Tucker, K. L, Jacques, P. F, Dallal, G. E, Wilson, P. W., Wood, R. J (2002). Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort. Am. J. Clin. Nutr. 76: 1375-1384 [Abstract] [Full Text]  
• Sempos, C. T (2002). Do body iron stores increase the risk of developing coronary heart disease?. Am. J. Clin. Nutr. 76: 501-503 [Full Text]  
• Wu, T.-H., Lee, T.-K., Yen, M.-F., Tung, T.-H., Chen, T. H.-H. (2002). Long-term mortality assessment using biological measures among elderly people. Ten-year follow-up of 597 healthy elderly subjects in Taiwan. Fam Pract 19: 272-277 [Abstract] [Full Text]  
• Haidari, M., Javadi, E., Sanati, A., Hajilooi, M., Ghanbili, J. (2001). Association of Increased Ferritin with Premature Coronary Stenosis in Men. Clin. Chem. 47: 1666-1672 [Abstract] [Full Text]  
• Fleming, D. J, Jacques, P. F, Tucker, K. L, Massaro, J. M, D'Agostino, R. B Sr, Wilson, P. W., Wood, R. J (2001). Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am. J. Clin. Nutr. 73: 638-646 [Abstract] [Full Text]  
• FREIDANK, H. M., BILLING, H., WIEDMANN-AL-AHMAD, M. (2001). Influence of iron restriction on Chlamydia pneumoniae and C. trachomatis. J Med Microbiol 50: 223-227 [Abstract] [Full Text]  
• Ascherio, A., Rimm, E. B., Giovannucci, E., Willett, W. C., Stampfer, M. J. (2001). Blood Donations and Risk of Coronary Heart Disease in Men. Circulation 103: 52-57 [Abstract] [Full Text]  
• Goodnough, L. T., Skikne, B., Brugnara, C. (2000). Erythropoietin, iron, and erythropoiesis. Blood 96: 823-833 [Abstract] [Full Text]  
• Roest, M., van der Schouw, Y. T., de Valk, B., Marx, J. J. M., Tempelman, M. J., de Groot, P. G., Sixma, J. J., Banga, J. D. (1999). Heterozygosity for a Hereditary Hemochromatosis Gene Is Associated With Cardiovascular Death in Women. Circulation 100: 1268-1273 [Abstract] [Full Text]  
• de Valk, B., Marx, J. J. M. (1999). Iron, Atherosclerosis, and Ischemic Heart Disease. Arch Intern Med 159: 1542-1548 [Abstract] [Full Text]  
• Klipstein-Grobusch, K., Koster, J. F, Grobbee, D. E, Lindemans, J., Boeing, H., Hofman, A., Witteman, J. C. (1999). Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 69: 1231-1236 [Abstract] [Full Text]  
• Danesh, J., Appleby, P. (1999). Coronary Heart Disease and Iron Status : Meta-Analyses of Prospective Studies. Circulation 99: 852-854 [Abstract] [Full Text]  
• Yang, Q., McDonnell, S. M., Khoury, M. J., Cono, J., Parrish, R. G. (1998). Hemochromatosis-Associated Mortality in the United States from 1979 to 1992: An Analysis of Multiple-Cause Mortality Data. ANN INTERN MED 129: 946-953 [Abstract] [Full Text]  
• Adamson, J. W., Eschbach, J. W. (1998). Erythropoietin for End-Stage Renal Disease. NEJM 339: 625-627 [Full Text]  
• Tuomainen, T.-P., Punnonen, K., Nyyssonen, K., Salonen, J. T. (1998). Association Between Body Iron Stores and the Risk of Acute Myocardial Infarction in Men. Circulation 97: 1461-1466 [Abstract] [Full Text]  
• Kiechl, S., Willeit, J., Egger, G., Poewe, W., Oberhollenzer, F., Group, f. t. B. S. (1997). Body Iron Stores and the Risk of Carotid Atherosclerosis : Prospective Results From the Bruneck Study. Circulation 96: 3300-3307 [Abstract] [Full Text]  
• Dabbagh, A. J., Shwaery, G. T., Keaney, J. F. Jr, Frei, B. (1997). Effect of Iron Overload and Iron Deficiency on Atherosclerosis in the Hypercholesterolemic Rabbit. Arterioscler. Thromb. Vasc. Bio. 17: 2638-2645 [Abstract] [Full Text]  
• Whittaker, P., Hines, F. A., Robl, M. G., Dunkel, V. C. (1996). Histopathological Evaluation of Liver, Pancreas, Spleen, and Heart from Iron-Overloaded Sprague-Dawley Rats*1,2. Toxicol Pathol 24: 558-563 [Abstract]  
• Ginsburg, G. S., Agil, A., O'Toole, M., Rimm, E., Douglas, P. S., Rifai, N. (1996). Effects of a Single Bout of Ultraendurance Exercise on Lipid Levels and Susceptibility of Lipids to Peroxidation in Triathletes. JAMA 276: 221-225 [Abstract]  
• Araujo, J. A., Romano, E. L., Brito, B. E., Parthe, V., Romano, M., Bracho, M., Montano, R. F., Cardier, J. (1995). Iron Overload Augments the Development of Atherosclerotic Lesions in Rabbits. Arterioscler. Thromb. Vasc. Bio. 15: 1172-1180 [Abstract] [Full Text]  
• Craig, W. Y., Poulin, S. E., Palomaki, G. E., Neveux, L. M., Ritchie, R. F., Ledue, T. B. (1995). Oxidation-Related Analytes and Lipid and Lipoprotein Concentrations in Healthy Subjects. Arterioscler. Thromb. Vasc. Bio. 15: 733-739 [Abstract] [Full Text]  
• Sullivan, J. L. (1995). Hemochromatosis and Coronary Artery Disease. JAMA 273: 25-26 [Abstract]  
• Salonen, J. T., Nyyssonen, K., Salonen, R., Giles, W. H., Anda, R. F., Williamson, D. F., Yip, R., Marks, J., Sempos, C. T., Looker, A. C., Gillum, R. F., Makuc, D. M. (1994). Body Iron Stores and the Risk of Coronary Heart Disease. NEJM 331: 1159-1160 [Full Text]  
• Miller, M., Hutchins, G. M. (1994). Hemochromatosis, Multiorgan Hemosiderosis, and Coronary Artery Disease. JAMA 272: 231-233 [Abstract]  
• Ascherio, A., Willett, W. C. (1994). Are Body Iron Stores Related to the Risk of Coronary Heart Disease?. NEJM 330: 1152-1154 [Full Text]